CRF Bracket announced the launch of a new Planning module added within SmartSupplies. Offering simplicity, visualization and control to life science companies, this module makes SmartSupplies the only fully integrated, 21 CRF Part 11compliant solution that enables closed-loop conduct of clinical supply forecasting, planning and inventory management.
The SmartSupplies Planning module will modernize how life science companies generate clinical supply manufacturing plans, replacing cumbersome, tedious spreadsheets. It dynamically graphs clinical supply and demand at the project and program levels using real-time forecast data pulled in directly from the SmartSupplies Forecasting module or from any other external sources such as simulation tools and spreadsheets.
Using the Smart Supplies Planning, Forecasting, and Inventory Management as a completely integrated solution produces a comprehensive end-to-end solution that digitally controls, tracks and traces the entire clinical supply chain. The Planning Module can also be used as a standalone solution to collate and visualize disparate sources of imported demand to enable aggregated supply and asset planning.
“Clinical supply chains can be complex to manage due to variability that results from protocol changes, undefined doses, unexpected recruitment rates, batch failures and non-availability of raw materials, among other challenges,” says Oliver Cunningham, Senior Director of Client Enablement, SmartSupplies, CRF Bracket.“SmartSupplies changes that-it’s purpose-built to fully digitize the entire clinical supply chain. By integratingforecasting, planning and inventory managementthe system enables on-demand lot recall and offers full traceability.”
The SmartSupplies Forecasting & Planning solutions will help sponsors reduce the effort required to build forecasts, make better manufacturing decisions, and reduce supply overages and associated costs. Companies like AstraZenecahave already made the enterprise-wide switch from Excel to SmartSupplies, saving 10% of their clinical supply budget, representing millions of US dollars annually, through better forecasting. The addition of the SmartSupplies Planning model will further increase the visibility of all supply chain activities and allow the system to optimize manufacturing plans thereby lowing the risk of stockouts or overproduction of investigational medicinal product.
To learn more about SmartSupplies Forecasting & Planning and SmartSupplies Inventory Management, visit http://pages.crfhealth.com/SmartSupplies_Forecasting_Planning.html
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.